Abstract
Introduction: Pelvic floor dysfunction (PFD) is a pathological condition that significantly impacts women’s health. It is therefore necessary to correctly diagnose it and offer the most appropriate treatment for her. Patient-reported outcomes (PROs) have been established, which include questionnaires measuring quality of life (QoL) and symptoms. Although several English-language questionnaires are available to assess PFDs and QoL concerns, relatively few have been validated for use in Italian. With a focus on validated PROs in Italian for assessing PFDs, this article aimed to provide a systematic overview of the literature with useful information on references and advice on how to access each unique questionnaire. Methods: Up until March 1, 2024, a systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The PubMed/MEDLINE databases and websites were utilized to locate validated Italian-language PFD surveys. The text provides instructions on how to receive a copy of the questionnaire if it has been identified and confirmed to be possible. Results: Thirty-five Italian-validated questionnaires were included: 17 out of 35 (48.6%) questionnaires focused on lower urinary tract symptoms, 1 (2.8%) on genital prolapse symptoms, 8 (22.8%) on sexuality, 3 (8.6%) on bowel symptoms, and 6 (17.2%) on pelvic dysfunctions. The literature search turned up seven more. Italian PRO validation documents compared to the last analysis. The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), the Sexual Desire and Erotic Fantasies (SDEF) Questionnaire, the Sexual Inhibition/Sexual Excitation Scales (SIS/SES), the 12-Item Sexual Distress Scale (SDS) and 5-Item Sexual Distress Scale-Short Form (SDS-SF), the questionnaires from Vaizey and Wexner and the fecal incontinence severity index (FISI), the Pelvic Floor Distress Inventory (PFDI-20), and the Intermittent Catheterization Acceptance Test (I-CAT) are among the specifically newly validated PROs. Conclusions: In order to encourage the use of suitable PROs while examining PFDs in Italian patients, this systematic review is meant to be a useful tool.
Journal Section:
Systematic Review
References
1.
Ge
J
, Wei
XJ
, Zhang
HZ
, Fang
GY
. Pelvic floor muscle training in the treatment of pelvic organ prolapse: a meta-analysis of randomized controlled trials
. Actas Urol Esp Engl Ed
. 2021
;45
(1
):73
–82
. 2.
Palmieri
S
, De Bastiani
SS
, Degliuomini
R
, Ruffolo
AF
, Casiraghi
A
, Vergani
P
, et al. Prevalence and severity of pelvic floor disorders in pregnant and postpartum women
. Int J Gynaecol Obstet
. 2022
;158
(2
):346
–51
. 3.
Frigerio
M
, Mastrolia
SA
, Spelzini
F
, Manodoro
S
, Yohay
D
, Weintraub
AY
. Long-term effects of episiotomy on urinary incontinence and pelvic organ prolapse: a systematic review
. Arch Gynecol Obstet
. 2019
;299
(2
):317
–25
. 4.
Manodoro
S
, Frigerio
M
, Cola
A
, Spelzini
F
, Milani
R
. Risk factors for recurrence after hysterectomy plus native-tissue repair as primary treatment for genital prolapse
. Int Urogynecol J
. 2018
;29
(1
):145
–51
. 5.
Frigerio
M
, Regini
C
, Manodoro
S
, Spelzini
F
, Milani
R
. Mini-sling efficacy in obese versus non-obese patients for treatment of stress urinary incontinence
. Minerva Ginecol
. 2017
;69
(6
):533
–7
. 6.
Manodoro
S
, Spelzini
F
, Cesana
MC
, Frigerio
M
, Maggioni
D
, Ceresa
C
, et al. Histologic and metabolic assessment in a cohort of patients with genital prolapse: preoperative stage and recurrence investigations
. Minerva Ginecol
. 2017
;69
(3
):233
–8
. 7.
Good
MM
, Solomon
ER
. Pelvic floor disorders
. Obstet Gynecol Clin Nord Am
. 2019
;46
(3
):527
–40
. 8.
Melville
JL
, Miller
EA
, Fialkow
MF
, Lentz
GM
, Miller
JL
, Fenner
DE
. Relationship between patient report and physician assessment of urinary incontinence severity
. Am J Obstet Gynecol
. 2003
;189
(1
):76
–80
. 9.
Frigerio
M
, Barba
M
, Cola
A
, Braga
A
, Celardo
A
, Munno
GM
, et al. Quality of life, psychological wellbeing, and sexuality in women with urinary incontinence: where are we now: a narrative review
. Medicina
. 2022
;58
(4
):525
. 10.
Dheresa
M
, Worku
A
, Oljira
L
, Mengiste
B
, Assefa
N
, Berhane
Y
. One in five women suffer from pelvic floor disorders in Kersa district Eastern Ethiopia: a community-based study
. BMC Womens Health
. 2018
;18
(1
):95
. 11.
Food and Drug Administration (FDA)
. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims
. Fed Regist
. 2009
;74
(235
):65132
–3
.12.
Kelleher
C
, Staskin
D
, Cherian
P
, Recommendation of the Internation, al Scientific Committee
, et al. Patient-reported out-come assessment
. In: Abrams
P
, Cardozo
L
, Khoury
S
, Wein
A
, editors. 5th international consultation on incontinence
. Paris, France
: Health Publications
; 2013
.13.
Streiner DLNG
. Health measurement scales
. Oxford
: OUP
; 1989
.14.
Revicki
DA
, Osoba
D
, Fairclough
D
, Barofsky
I
, Berzon
R
, Leidy
NK
, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
. Qual Life Res
. 2000
;9
(8
):887
–900
. 15.
Murawski
MM
, Miederhoff
PA
. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis
. Qual Life Res
. 1998
;7
(1
):11
–22
. 16.
Acquadro
C
, Conway
K
, Hareendran
A
, Aaronson
N
, European Regulatory Issues and Quality of Life Assessment ERIQA Group
. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials
. Value Health
. 2008
;11
(3
):509
–21
. 17.
Braga
A
, Barba
M
, Serati
M
, Soligo
M
, Li Marzi
V
, Finazzi Agrò
E
, et al. Update on Italian-validated questionnaires for pelvic floor disorders
. Minerva Obstet Gynecol
. 2023
;75
(1
):62
–8
. 18.
Page
MJ
, McKenzie
JE
, Bossuyt
PM
, Boutron
I
, Hoffmann
TC
, Mulrow
CD
, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
. BMJ
. 2021
;372
:n71
. 19.
Tubaro
A
, Zattoni
F
, Prezioso
D
, Scarpa
RM
, Pesce
F
, Rizzi
CA
, Flow Study Group
, et al. Italian validation of the international consultation on incontinence questionnaires
. BJU Int
. 2006
;97
(1
):101
–8
. 20.
De Gennaro
M
, Niero
M
, Capitanucci
ML
, von Gontard
A
, Woodward
M
, Tubaro
A
, et al. Validity of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms: a screening questionnaire for children
. J Urol
. 2010
;184
(4 Suppl l
):1662
–7
. 21.
22.
Artibani
W
, Pesce
F
, Prezioso
D
, Scarpa
RM
, Zattoni
F
, Tubaro
A
, Flow Study Group
, et al. Italian validation of the urogenital distress inventory and its application in LUTS patients
. Eur Urol
. 2006
;50
(6
):1323
–9
. 23.
Monticone
M
, Frigau
L
, Mola
F
, Rocca
B
, Giordano
A
, Foti
C
, et al. Italian versions of the Urogenital Distress Inventory-6 and Incontinence Impact Questionnaire-7: translation and validation in women with urinary incontinence
. Disabil Rehabil
. 2021
;43
(20
):2930
–6
. 24.
Bushnell
DM
, Martin
ML
, Summers
KH
, Svihra
J
, Lionis
C
, Patrick
DL
. Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOL
. Qual Life Res
. 2005
;14
(8
):1901
–13
. 25.
Possavino
F
, Preti
M
, Carone
R
, Calabrese
R
, Randaccio
S
, D'Elia
C
, et al. Psychometric validation of the Italian version of the I-QoL questionnaire: clinical and urodynamic findings
. Int Urogynecol J
. 2013
;24
(12
):2125
–30
. 26.
Acquadro
C
, Kopp
Z
, Coyne
KS
, Corcos
J
, Tubaro
A
, Choo
MS
, et al. Translating overactive bladder questionnaires in 14 languages
. Urology
. 2006
;67
(3
):536
–40
. 27.
McKown
S
, Abraham
L
, Coyne
K
, Gawlicki
M
, Piault
E
, Vats
V
. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages
. Int J Clin Pract
. 2010
;64
(12
):1643
–52
. 28.
Giubilei
G
, Mondaini
N
, Crisci
A
, Raugei
A
, Lombardi
G
, Travaglini
F
, et al. The Italian version of the national institutes of health chronic prostatitis symptom index
. Eur Urol
. 2005
;47
(6
):805
–11
. 29.
Bonniaud
V
, Bryant
D
, Pilati
C
, Menarini
M
, Lamartina
M
, Guyatt
G
, et al. Italian version of Qualiveen-30: cultural adaptation of a neurogenic urinary disorder-specific instrument
. Neurourol Urodyn
. 2011
;30
(3
):354
–9
. 30.
Badia
X
, García-Losa
M
, Dal-Ré
R
. Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials
. Eur Urol
. 1997
;31
(2
):129
–40
. 31.
Bertaccini
A
, Martinelli
A
, Ceccarelli
R
, Palmieri
F
, Vitullo
G
, Urbinati
M
, et al. Development and validation of the BSP-BPH (Bononian Satisfaction Profile-Benign Prostatic Hyperplasia) a “disease-specific” questionnaire for the evaluation of health related quality of life in patients with benign prostatic hyperplasia
. Arch Ital Urol Androl
. 2004
;76
(3
):103
–9
.32.
Di Vico
T
, Morganti
R
, Cai
T
, Naber
KG
, Wagenlehner
FME
, Pilatz
A
, et al. Acute cystitis symptom score (ACSS): clinical validation of the Italian version
. Antibiot
. 2020
;9
(3
):E104
. 33.
Digesu
GA
, Santamato
S
, Khullar
V
, Santillo
V
, Digesu
A
, Cormio
G
, et al. Validation of an Italian version of the prolapse quality of life questionnaire
. Eur J Obstet Gynecol Reprod Biol
. 2003
;106
(2
):184
–92
. 34.
Rellini
AH
, Nappi
RE
, Vaccaro
P
, Ferdeghini
F
, Abbiati
I
, Meston
CM
. Validation of the McCoy female sexuality questionnaire in an Italian sample
. Arch Sex Behav
. 2005
;34
(6
):641
–7
. 35.
Nappi
RE
, Albani
F
, Vaccaro
P
, Gardella
B
, Salonia
A
, Chiovato
L
, et al. Use of the Italian translation of the female sexual function index (FSFI) in routine gynecological practice
. Gynecol Endocrinol
. 2008
;24
(4
):214
–9
. 36.
Filocamo
MT
, Serati
M
, Li Marzi
V
, Costantini
E
, Milanesi
M
, Pietropaolo
A
, et al. The female sexual function index (FSFI): linguistic validation of the Italian version
. J Sex Med
. 2014
;11
(2
):447
–53
. 37.
Symonds
T
, Boolell
M
, Quirk
F
. Development of a questionnaire on sexual quality of life in women
. J Sex Marital Ther
. 2005
;31
(5
):385
–97
. 38.
Casu
G
. Development and initial validation of the Positive Sexuality Scale for female adults
. J Clin Nurs
. 2019
;28
(7–8
):1289
–99
. 39.
Volonte
S
, Barba
M
, Cola
A
, Marino
G
, Frigerio
M
. Italian validation of the short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12)
. Int Urogynecol J
. 2022
;33
(11
):3171
–5
. 40.
Nimbi
FM
, Galizia
R
, Fontanesi
L
, Soyman
S
, Jannini
EA
, Simonelli
C
, et al. Sexual desire and erotic fantasies questionnaire: validation of the erotic fantasy inventory scale (SDEF 3) in Italian adults
. Healthc
. 2023
;11
(6
):880
. 41.
Panzeri
M
, Dadomo
H
, Ronconi
L
, Fontanesi
L
. Validation of the sexual inhibition/sexual excitation scales (SIS/SES) in Italy: assessing gender and age differences of sexual functioning
. Arch Sex Behav
. 2021
;50
(6
):2755
–72
. 42.
Galizia
R
, Tripodi
FM
, Rossi
R
, Michetti
PM
, Simonelli
C
, Nimbi
FM
. Italian versions of the 12-item sexual distress scale (SDS) and the 5-item sexual distress scale-short form (SDS-SF): psychometric properties
. J Sex Marital Ther
. 2023
;49
(2
):141
–54
. 43.
Altomare
DF
, Rinaldi
M
, Giardiello
GG
, Donelli
A
, Petrolino
M
, Villani
RD
, et al. Italian translation and prospectine validation of fecal incontinence quality of life (FIQL) index
. Chir Ital
. 2005
;57
(2
):153
–8
.44.
Altomare
DF
, Spazzafumo
L
, Rinaldi
M
, Dodi
G
, Ghiselli
R
, Piloni
V
. Set-up and statistical validation of a new scoring system for obstructed defaecation syndrome
. Colorectal Dis
. 2008
;10
(1
):84
–8
. 45.
Ortenzi
M
, Guerrieri
M
, Saraceno
F
, Reggiani
A
, Lepiane
P
, Sileri
P
, et al. Prospective Italian validation of the Vaizey and Wexner and fecal incontinence severity index (FISI) questionnaires
. Updates Surg
. 2023
;75
(6
):1617
–23
. 46.
Radley
SC
, Jones
GL
, Tanguy
EA
, Stevens
VG
, Nelson
C
, Mathers
NJ
. Computer interviewing in urogynaecology: concept, development and psychometric testing of an electronic pelvic floor assessment questionnaire in primary and secondary care
. BJOG
. 2006
;113
(2
):231
–8
. 47.
Soligo
M
, Roberti Maggiore
UL
, Oprandi
NC
, Nelva Stellio
L
, De Ponti
E
, Del Popolo
G
, et al. Electronic personal assessment questionnaire-pelvic floor: Italian cultural adaptation and face validity
. Urologia
. 2019
;86
(2
):86
–92
. 48.
Conti
A
, Clari
M
, Arese
S
, Bandini
B
, Cavallaro
L
, Mozzone
S
, et al. Validation and psychometric evaluation of the Italian version of the spinal cord injury secondary conditions scale
. Spinal Cord
. 2020
;58
(4
):496
–503
. 49.
Monti
M
, Marquez
MA
, Berardi
A
, Tofani
M
, Valente
D
, Galeoto
G
. The Multiple Sclerosis Intimacy and Sexuality Questionnaire (MSISQ-15): validation of the Italian version for individuals with spinal cord injury
. Spinal Cord
. 2020
;58
(10
):1128
–33
. 50.
Palmieri
S
, Cola
A
, Ceccherelli
A
, Manodoro
S
, Frigerio
M
, Vergani
P
. Italian validation of the German Pelvic Floor Questionnaire for pregnant and postpartum women
. Eur J Obstet Gynecol Reprod Biol
. 2020
;248
:133
–6
. 51.
Barba
M
, Cola
A
, Melocchi
T
, Braga
A
, Castronovo
F
, Manodoro
S
, et al. Italian validation of the pelvic floor distress inventory (PFDI-20) questionnaire
. Int Urogynecol J
. 2023
;34
(10
):2459
–65
. 52.
Berardi
A
, Marquez
MA
, Ottone
L
, Ruotolo
I
, Panuccio
F
, Tofani
M
, et al. Italian translation, cultural adaptation, and validation of the Intermittent Catheterization Acceptance Test (I-CAT)
. Clin Ter
. 2023
;174
(1
):8
–13
. 53.
Nygaard
I
, Barber
MD
, Burgio
KL
, Kenton
K
, Meikle
S
, Schaffer
J
, et al. Prevalence of symptomatic pelvic floor disorders in US women
. Jama
. 2008
;300
(11
):1311
–6
. 54.
Mosca
L
, Riemma
G
, Braga
A
, Frigerio
M
, Ruffolo
AF
, Dominoni
M
, et al. Female sexual dysfunctions and urogynecological complaints: a narrative review
. Med Kaunas
. 2022
;58
(8
):981
. 55.
Verbeek
M
, Hayward
L
. Pelvic floor dysfunction and its effect on quality of sexual life
. Sex Med Rev
. 2019
;7
(4
):559
–64
. 56.
Stafne
SN
, Ulven
KS
, Prøsch-Bilden
T
, Saga
S
. Pelvic floor disorders and impact on sexual function: a cross-sectional study among non–sexually active and sexually active women
. Sex Med
. 2024
;12
(2
):qfae024
. 57.
Serati
M
, Braga
A
, Di Dedda
MC
, Sorice
P
, Peano
E
, Biroli
A
, et al. Benefit of pelvic floor muscle therapy in improving sexual function in women with stress urinary incontinence: a pretest-posttest intervention study
. J Sex Marital Ther
. 2015
;41
(3
):254
–61
. 58.
Nambiar
AK
, Arlandis
S
, Bø
K
, Cobussen-Boekhorst
H
, Costantini
E
, de Heide
M
, et al. European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. Part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence
. Eur Urol
. 2022
;82
(1
):49
–59
. 59.
Vilos
GA
, Reyes-MuÑoz
E
, Riemma
G
, Kahramanoglu
I
, Lin
LT
, Chiofalo
B
, et al. Gynecological cancers and urinary dysfunction: a comparison between endometrial cancer and other gynecological malignancies
. Minerva Med
. 2021
;112
(1
):96
–110
. 60.
van Reijn-Baggen
DA
, Han-Geurts
IJM
, Voorham-van der Zalm
PJ
, Pelger
RCM
, Hagenaars-van Miert
CHAC
, Laan
ETM
. Pelvic floor physical therapy for pelvic floor hypertonicity: a systematic review of treatment efficacy
. Sex Med Rev
. 2022
;10
(2
):209
–30
. 61.
De Franciscis
P
, Cobellis
L
, Fornaro
F
, Sepe
E
, Torella
M
, Colacurci
N
. Low-dose hormone therapy in the perimenopause
. Int J Gynaecol Obstet
. 2007
;98
(2
):138
–42
. 62.
De Franciscis
P
, Conte
A
, Schiattarella
A
, Riemma
G
, Cobellis
L
, Colacurci
N
. Non-hormonal treatments for menopausal symptoms and sleep disturbances: a comparison between purified pollen extracts and soy isoflavones
. Curr Pharm Des
. 2020
;26
(35
):4509
–14
. 63.
Minassian
VA
. Can lower urinary tract symptoms and urinary incontinence in women Be prevented
. J Urol
. 2022
;207
(5
):958
–9
. 64.
Benini
V
, Ruffolo
AF
, Casiraghi
A
, Degliuomini
RS
, Frigerio
M
, Braga
A
, et al. New innovations for the treatment of vulvovaginal atrophy: an up-to-date review
. Med Kaunas
. 2022
;58
(6
):770
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
